Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FU945
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,633
Award facts
- Contract value 100% obligated
- $16,633.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,633.30 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) under a firm fixed price contract. The award, made on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a non-set-aside competitive procurement. XELJANZ XR is a branded pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions, fulfilling the military healthcare system's ongoing pharmaceutical supply requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a child contract under this substantial prime IDC, the XELJANZ XR delivery order exemplifies the company's role in supplying specialty medications and brand-name drugs to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FU945?
SPE2DR26FU945 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FU945 worth?
The government has obligated $16,633 on SPE2DR26FU945.
Is contract SPE2DR26FU945 an order under another contract?
Yes. SPE2DR26FU945 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU945 competed?
The extent of competition for SPE2DR26FU945 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award